Mary Christian
About Mary Christian
Mary Christian serves as the Senior Vice President of Regulatory & Quality at Lyndra Therapeutics, bringing extensive experience in regulatory affairs and quality management from her previous roles at various pharmaceutical companies.
Work at Lyndra Therapeutics
Mary Christian serves as the Senior Vice President of Regulatory & Quality at Lyndra Therapeutics, a position she has held since 2020. In this role, she oversees regulatory affairs and quality assurance processes, ensuring compliance with industry standards and regulations. Her leadership contributes to the company's mission of advancing innovative drug delivery systems. The organization is based in Watertown, Massachusetts, where she has been instrumental in shaping regulatory strategies and quality protocols.
Previous Experience in Pharmaceutical Industry
Mary Christian has extensive experience in the pharmaceutical industry, having held various leadership roles. She worked at Bristol-Myers Squibb in multiple capacities, including Head of Strategic Collaborations Group for US Oncology and Head of Mature Products Strategy. Her tenure at Cyclerion as Vice President of Global Quality, Regulatory & Safety, and at Ironwood Pharmaceuticals as Head of Global Regulatory Affairs further solidified her expertise in regulatory strategy and quality management.
Educational Background and Qualifications
Mary Christian holds a Bachelor of Science in Pharmacy from Rutgers University and a Doctor of Pharmacy (Pharm.D.) from the University of Florida. She also earned an MBA in Pharmaceutical Business from the University of the Sciences in Philadelphia. Additionally, she completed the FT Board Director Programme, achieving a Non-Executive Director Diploma in 2022. Her educational background supports her extensive knowledge in regulatory affairs and pharmaceutical management.
Expertise in Regulatory Affairs and Quality Management
Mary Christian specializes in regulatory affairs and quality management, with a strong focus on US FDA regulatory approvals and negotiations. Her expertise includes cross-therapeutic area mature product portfolio rationalization and pediatric drug development. She has experience managing regulatory strategies from Phase 1 to Phase 4 of global drug development, contributing to her reputation as a knowledgeable leader in the field.
Board Membership and Community Involvement
Mary Christian served as a Trustee on the Board of Directors for the Center for Great Expectations from 2007 to 2019. In this role, she contributed to the organization's mission and strategic direction. Her involvement reflects a commitment to community service and leadership beyond her professional responsibilities in the pharmaceutical industry.